Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Tom van Meerten is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Facts and hopes for PET imaging-derived immunotherapy biomarkers
de Groot, D. J. A., Lub-de Hooge, M. N., van Meerten, T., Brouwers, A. H. & de Vries, E. G. E., Dec-2024, In: Clinical Cancer Research. 30, 23, p. 5252–5259 8 p.Research output: Contribution to journal › Review article › peer-review
-
High frequency of severe hyperglycemia observed during intensive hematological care: a prospective study using continuous glucose monitoring
Tienstra, M., de Boer, J. W., van Doesum, J. A., Keijzer, K., Morsink, L. M., Hazenberg, C. L. E., Ammatuna, E., Huls, G. A., Choudhary, P., Gans, R. O. B., Wiersma, V. R., van Meerten, T. & van Dijk, P. R., Dec-2024, In: Endocrine practice. 30, 12, p. 1141-1148 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile16 Downloads (Pure) -
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
Dreyling, M., Doorduijn, J., Giné, E., Jerkeman, M., Walewski, J., Hutchings, M., Mey, U., Riise, J., Trneny, M., Vergote, V., Shpilberg, O., Gomes da Silva, M., Leppä, S., Jiang, L., Stilgenbauer, S., Kerkhoff, A., Jachimowicz, R. D., Celli, M., Hess, G. & Arcaini, L. & 18 others, , 25-May-2024, In: The Lancet. 403, 10441, p. 2293-2306 14 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile21 Citations (Scopus)31 Downloads (Pure) -
Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids
Oluwole, O. O., Forcade, E., Muñoz, J., de Guibert, S., Vose, J. M., Bartlett, N. L., Lin, Y., Deol, A., McSweeney, P., Goy, A. H., Kersten, M. J., Jacobson, C. A., Farooq, U., Minnema, M. C., Thieblemont, C., Timmerman, J. M., Stiff, P., Avivi, I., Tzachanis, D. & Zheng, Y. & 6 others, , Mar-2024, In: Bone marrow transplantation. 59, p. 366–372 7 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile3 Citations (Scopus)31 Downloads (Pure) -
Reducing and controlling metabolic active tumor volume prior to CAR T-cell infusion can improve survival outcomes in patients with large B-cell lymphoma
Keijzer, K., de Boer, J. W., van Doesum, J. A., Noordzij, W., Huls, G. A., van Dijk, L. V., van Meerten, T. & Niezink, A. G. H., 7-Mar-2024, In: Blood cancer journal. 14, 1, 9 p., 41.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile6 Citations (Scopus)91 Downloads (Pure)
Activities
- 1 Supervision and examination of PhD students of the UG
-
R. Bouwstra; Innate immune checkpoint inhibitors for treatment of diffuse large B-cell lymphoma
Laman, J. D. (Member of PhD Examining Committee), Bremer, E. (Supervisor), Huls, G. (Supervisor) & van Meerten, T. (Co-supervisor)
21-Sept-2022Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
Datasets
-
Additional file 1 of DSP107 combines inhibition of CD47/SIRPα axis with activation of 4-1BB to trigger anticancer immunity
Cendrowicz, E. (Contributor), Jacob, L. (Contributor), Greenwald, S. (Creator), Tamir, A. (Creator), Pecker, I. (Creator), Tabakman, R. (Creator), Ghantous, L. (Creator), Tamir, L. (Creator), Kahn, R. (Creator), Avichzer, J. (Creator), Aronin, A. (Creator), Amsili, S. (Creator), Zorde-Khvalevsky, E. (Creator), Gozlan, Y. (Creator), Vlaming, M. (Contributor), Huls, G. (Creator), van Meerten, T. (Contributor), Dranitzki, M. E. (Creator), Foley-Comer, A. (Creator), Pereg, Y. (Creator), Peled, A. (Creator), Chajut, A. (Creator) & Bremer, E. (Creator), figshare, 14-Mar-2022
DOI: 10.6084/m9.figshare.19359964, https://springernature.figshare.com/articles/dataset/Additional_file_1_of_DSP107_combines_inhibition_of_CD47_SIRP_axis_with_activation_of_4-1BB_to_trigger_anticancer_immunity/19359964
Dataset
Press/Media
-
Groningse CAR-T-celtherapie krijgt KWF-subsidie
29/01/2024
1 item of Media coverage
Press/Media: Expert Comment › Popular
-
Hoe een Gronings ziekenhuis het opneemt tegen big pharma
Kosterink, J. & van Meerten, T.
12/10/2023
1 Media contribution
Press/Media: Expert Comment › Popular
-
Axi-cel CAR-T significantly improves EFS among older patients with non-Hodgkin lymphoma
16/02/2022
1 item of Media coverage
Press/Media: Research › Popular
-
-
UMCG gaat zelf medicijn tegen lymfeklierkanker maken
26/09/2021
1 Media contribution
Press/Media: Other › Popular